...
首页> 外文期刊>Journal of Anaesthesiology Clinical Pharmacology >The effect of esmolol compared to opioids on postoperative nausea and vomiting, postanesthesia care unit discharge time, and analgesia in noncardiac surgery: A meta-analysis
【24h】

The effect of esmolol compared to opioids on postoperative nausea and vomiting, postanesthesia care unit discharge time, and analgesia in noncardiac surgery: A meta-analysis

机译:艾司洛尔与阿片类药物相比对非心脏手术术后恶心和呕吐,麻醉后护理单位出院时间和镇痛作用的影响:荟萃分析

获取原文
           

摘要

Background and Aims: Perioperative esmolol as an opioid alternative has been shown to reduce postoperative nausea vomiting using opioid sparing. The aim of this meta-analysis was to compare esmolol and opioids on postoperative nausea and vomiting (PONV), time spent in recovery, and analgesia in noncardiac surgeries. Material and Methods: OVID Medline (1980–February 2014), OVID EMBASE, EBSCO, CINAHL, and the Cochrane Register of Controlled Trials were searched for randomized controlled trials (RCTs) comparing esmolol and opioids on early postoperative recovery and pain intensity during general anesthesia in noncardiac surgeries. The primary outcomes were related to PONV and postanesthesia care unit (PACU) discharge time, whereas secondary outcomes were related to early postoperative pain. Results: Eight trials were identified involving 439 patients, 228 of whom received esmolol while 211 received opioids. A random-effects meta-analysis showed that in comparison with opioids, esmolol led to a 69% reduction in the incidence of PONV (odds ratio 0.31, 95% confidence interval [CI] 0.13–0.74, P = 0.008, I2 = 44.1%). An increase in the volatile anesthetic requirement was evident in the esmolol group compared with opioid (MD + 0.67% desflurane equivalent, 95% CI 0.27–1.08, P = 0.001, I2 =23.5%). There was no statistically significant difference between the esmolol and opioid groups in relation to PACU discharge time, early postoperative pain scores, opioid requirement, and cumulative opioid consumption. Significant heterogeneity was noted between studies. No significant adverse effects were noted. Conclusion: Compared with opioids, perioperative esmolol may reduce the incidence of postoperative nausea vomiting and increase the volatile anesthetic requirement. Esmolol administration may not improve the early postoperaive pain intensity. Nonetheless, these findings are limited by the absence of high-quality RCTs and the heterogeneity among studies. Further, large-scale studies are needed to explore these results.
机译:背景与目的:围手术期使用艾司洛尔作为阿片类药物的替代品已被证明可减少使用阿片类药物的术后恶心呕吐。这项荟萃分析的目的是比较艾司洛尔和阿片类药物对非心脏手术患者术后恶心和呕吐(PONV),恢复所花费的时间以及镇痛的作用。材料和方法:搜寻OVID Medline(1980年至2014年2月),OVID EMBASE,EBSCO,CINAHL和Cochrane对照试验注册资料,以比较艾司洛尔和阿片类药物在全身麻醉期间早期恢复和疼痛强度方面的随机对照试验(RCT)。在非心脏手术中。主要结局与PONV和麻醉后护理单元(PACU)出院时间有关,而次要结局与术后早期疼痛有关。结果:确定了八项试验,涉及439例患者,其中228例接受艾司洛尔,而211例接受阿片类药物。一项随机效应荟萃分析表明,与阿片类药物相比,艾司洛尔导致PONV的发生率降低了69%(比值0.31,95%置信区间[CI] 0.13-0.74,P = 0.008,I 2 = 44.1%)。与阿片类药物相比,艾司洛尔组的挥发性麻醉剂需求量明显增加(MD + 0.67%地氟醚当量,95%CI 0.27–1.08,P = 0.001,I 2 = 23.5%)。艾司洛尔和阿片类药物组之间在PACU出院时间,术后早期疼痛评分,阿片类药物需要量和阿片类药物累积消耗方面无统计学差异。研究之间发现了显着的异质性。没有发现明显的不良反应。结论:与阿片类药物相比,围手术期艾司洛尔可减少术后恶心呕吐的发生率并增加挥发性麻醉剂的需求。艾司洛尔给药可能不会改善术后早期疼痛强度。尽管如此,这些发现由于缺乏高质量的RCT和研究之间的异质性而受到限制。此外,需要大规模研究来探索这些结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号